Quality of life and healthcare costs of patients with allergic respiratory diseases: a cross-sectional study
Hillerich V, Valbert F, Neusser S, Pfaar O, Klimek L, Sperl A, Werfel T, Hamelmann E, Riederer C, Wobbe-Ribinski S, Neumann A, et al. (2023)
European Journal of Health Economics.
Zeitschriftenaufsatz
| E-Veröff. vor dem Druck | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Hillerich, Vivienne;
Valbert, Frederik;
Neusser, Silke;
Pfaar, Oliver;
Klimek, Ludger;
Sperl, Annette;
Werfel, Thomas;
Hamelmann, EckardUniBi;
Riederer, Cordula;
Wobbe-Ribinski, Stefanie;
Neumann, Anja;
Wasem, Jurgen
Alle
Alle
Abstract / Bemerkung
BACKGROUND: Allergic rhinitis (AR) and allergic asthma (AA) are chronic respiratory diseases that represent a global health problem. One aim of this study was to analyze the Health-related Quality of Life (HRQoL) of the patients in order to identify statistically significant influencing factors that determine HRQoL. Another aim was to assess and analyze data on cost-of-illness from a statutory health insurance perspective.; METHODS: The EQ-5D-5L was used to evaluate the patients' HRQoL. To identify the factors influencing the HRQoL, a multinomial logistic regression analysis was conducted using groups based on the EQ-5D-5L index value as dependent variable. Routine data were analyzed to determine total healthcare costs.; RESULTS: The average EQ-5D-5L index was 0.85 (SD 0.20). A high age, the amount of disease costs, low internal health-related control beliefs and high ozone exposure in the residential area were found to be statistically significant influencing factors for a low HRQoL, whereas low age, male sex and a good possibility to avoid the allergens were found to be statistically significant factors influencing a high HRQoL. On average, the study participants incurred annual costs of 3072 (SD: 3485), of which 699 (SD: 743) could be assigned to allergic respiratory diseases.; CONCLUSIONS: Overall, the patients in the VerSITA study showed a high level of HRQoL. The identified influencing factors can be used as starting points for improving the HRQoL of patients with allergic respiratory diseases. From the perspective of a statutory health insurance, per person expenditures for allergic respiratory diseases are rather low. © 2023. The Author(s).
Erscheinungsjahr
2023
Zeitschriftentitel
European Journal of Health Economics
eISSN
1618-7601
Page URI
https://pub.uni-bielefeld.de/record/2980735
Zitieren
Hillerich V, Valbert F, Neusser S, et al. Quality of life and healthcare costs of patients with allergic respiratory diseases: a cross-sectional study. European Journal of Health Economics. 2023.
Hillerich, V., Valbert, F., Neusser, S., Pfaar, O., Klimek, L., Sperl, A., Werfel, T., et al. (2023). Quality of life and healthcare costs of patients with allergic respiratory diseases: a cross-sectional study. European Journal of Health Economics. https://doi.org/10.1007/s10198-023-01598-3
Hillerich, Vivienne, Valbert, Frederik, Neusser, Silke, Pfaar, Oliver, Klimek, Ludger, Sperl, Annette, Werfel, Thomas, et al. 2023. “Quality of life and healthcare costs of patients with allergic respiratory diseases: a cross-sectional study”. European Journal of Health Economics.
Hillerich, V., Valbert, F., Neusser, S., Pfaar, O., Klimek, L., Sperl, A., Werfel, T., Hamelmann, E., Riederer, C., Wobbe-Ribinski, S., et al. (2023). Quality of life and healthcare costs of patients with allergic respiratory diseases: a cross-sectional study. European Journal of Health Economics.
Hillerich, V., et al., 2023. Quality of life and healthcare costs of patients with allergic respiratory diseases: a cross-sectional study. European Journal of Health Economics.
V. Hillerich, et al., “Quality of life and healthcare costs of patients with allergic respiratory diseases: a cross-sectional study”, European Journal of Health Economics, 2023.
Hillerich, V., Valbert, F., Neusser, S., Pfaar, O., Klimek, L., Sperl, A., Werfel, T., Hamelmann, E., Riederer, C., Wobbe-Ribinski, S., Neumann, A., Wasem, J., Biermann-Stallwitz, J.: Quality of life and healthcare costs of patients with allergic respiratory diseases: a cross-sectional study. European Journal of Health Economics. (2023).
Hillerich, Vivienne, Valbert, Frederik, Neusser, Silke, Pfaar, Oliver, Klimek, Ludger, Sperl, Annette, Werfel, Thomas, Hamelmann, Eckard, Riederer, Cordula, Wobbe-Ribinski, Stefanie, Neumann, Anja, Wasem, Jurgen, and Biermann-Stallwitz, Janine. “Quality of life and healthcare costs of patients with allergic respiratory diseases: a cross-sectional study”. European Journal of Health Economics (2023).
Daten bereitgestellt von European Bioinformatics Institute (EBI)
Zitationen in Europe PMC
Daten bereitgestellt von Europe PubMed Central.
References
Daten bereitgestellt von Europe PubMed Central.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Quellen
PMID: 37414970
PubMed | Europe PMC
Suchen in